Theranyx, based in Marseille (Fr), is a leading drug Discovery Company involved in the generation of functional antibody fragments, named Therabodies, targeting integral membrane receptors such as GPCRs and Ion Channels. Therabodies' applications include target validation, diagnostics, therapeutic use and ADC. Theranyx business model includes both shared risk collaboration with biotech and pharma leaders and internal pipeline development on novel targets in cancer indications.
View Top Employees from Theranyx| Website | http://www.theranyx.com |
| Revenue | $809000 |
| Employees | View employees |
| Founded | 2010 |
| Address | Technopole Grand Luminy Case 922, Marseille, Provence-Alpes-Cote d'Azur, FR |
| Technologies |
HTML,
Google Analytics,
G Suite
+3 more
(view full list)
|
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Therapeutics, Health Care |
| Competitors | CymaBay Therapeutics, GENFIT, Innate Pharma, Transgene, TxCell |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Theranyx employee's phone or email?
Theranyx Questions
The Theranyx annual revenue was $809000 in 2024.
Theranyx is based in Marseille, Provence-Alpes-Cote d'Azur.
The NAICS codes for Theranyx are [541713, 54, 541, 54171, 5417].
The SIC codes for Theranyx are [873, 87].
